A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulin

Autor: Khanolkar, Rutvij A., Kalra, Amit, Kinzel, Megan, Pratt, Laura M., Dharmani-Khan, Poonam, Chaudhry, Ahsan, Williamson, Tyler S., Daly, Andrew, Morris, Don G., Khan, Faisal M., Storek, Jan
Zdroj: In Cytotherapy November 2021 23(11):1007-1016
Databáze: ScienceDirect
Externí odkaz: